Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 29, 2023
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
[ Wed, Nov 29th 2023
] - WOPRAI
Tue, November 28, 2023
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
[ Tue, Nov 28th 2023
] - WOPRAI
Brian Abrahams Maintained (XENE) at Buy with Increased Target to $56 on, Nov 28th, 2023
Brian Abrahams of RBC Capital, Maintained "Xenon Pharmaceuticals Inc." (XENE) at Buy with Increased Target from $51 to $56 on, Nov 28th, 2023.
Brian has made no other calls on XENE in the last 4 months.
There are 4 other peers that have a rating on XENE. Out of the 4 peers that are also analyzing XENE, 0 agree with Brian's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Brian
- Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $46 on, Thursday, November 9th, 2023
- Josh Schimmer of "Cantor Fitzgerald" Initiated at Buy on, Tuesday, October 24th, 2023
- Charles Duncan of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $58 on, Tuesday, August 22nd, 2023
- Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $50 on, Thursday, August 10th, 2023
